INTERNATIONAL PATENT: THE UNIVERSITY OF CHICAGO FILES APPLICATION FOR "BCL-2 INHIBITION TO AMPLIFY CHIMERIC ANTIGEN RECEPTOR THERAPY"

GENEVA, May 15 -- THE UNIVERSITY OF CHICAGO (5801 S. Ellis AvenueChicago, Illinois 60637) filed a patent application (PCT/US2024/054434) for "BCL-2 INHIBITION TO AMPLIFY CHIMERIC ANTIGEN RECEPTOR THERAPY" on Nov 04, 2024. With publication no. WO/2025/097150, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LABELLE, James L. (c/o The University of Chicago5801 S. Ellis AvenueChicago, Illinois 60637), ABOELELLA, Nada S. (c/o The University of Chicago5801 S. Ellis AvenueChicago, Illinois 60637)

Abstract: Provided herein are...